Zevra Therapeutics's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Zevra Therapeutics (NASDAQ:ZVRA) is set to release its latest quarterly earnings report on Monday, 2023-08-14. Analysts estimate an earnings per share (EPS) of $-0.39. Last quarter, the company missed EPS by $0.11, which was followed by a 7.11% increase in the share price. Shares of Zevra Therapeutics were trading at $4.99 as of August 10, and over the last 52-week period, shares are down 15.32%.
August 11, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zevra Therapeutics is expected to report an EPS of $-0.39 in its upcoming earnings report. Despite missing EPS estimates last quarter, the company's share price increased by 7.11%. However, the stock has been down 15.32% over the last 52 weeks.
The upcoming earnings report is a significant event for Zevra Therapeutics. The company's performance in the last quarter, despite missing EPS estimates, led to a share price increase, indicating that investors may have positive expectations. However, the overall negative return over the past year suggests a cautious outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100